Correction: The anthelmintic drug niclosamide induces GSK-β-mediated β-catenin degradation to potentiate gemcitabine activity, reduce immune evasion ability and suppress pancreatic cancer progression

Detalles Bibliográficos
Autores principales: Guo, Yangyang, Zhu, Hengyue, Xiao, Yanyi, Guo, Hangcheng, Lin, Miaomiao, Yuan, Ziwei, Yang, Xuejia, Huang, Youze, Zhang, Qiyu, Bai, Yongheng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Correction
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9018699/
https://www.ncbi.nlm.nih.gov/pubmed/35440080
http://dx.doi.org/10.1038/s41419-022-04705-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9018699/
https://www.ncbi.nlm.nih.gov/pubmed/35440080
http://dx.doi.org/10.1038/s41419-022-04705-z

Ejemplares similares